Locations:
Search IconSearch

Brain Tumor

Hydrogen sulfide

Can Boosting Hydrogen Sulfide Bolster Standard-of-Care Glioblastoma Therapy to Extend Survival?

Cleveland Clinic researchers pursue answers on basic science and clinical fronts

SpineBoard-CQD-Hero-650×450
June 23, 2023/Cancer

How and Why a Dedicated Spine Tumor Board Can Enhance Care of Complex Patients

Insights from 15 years of experience of Cleveland Clinic’s spine tumor board

Astrocy

Mitochondria Transfer From Healthy Astrocytes Fuels Glioblastoma Tumorigenicity

Study demonstrates its role in tumor lethality, raises prospect of therapeutic targets

MRI of a patient with brain metastases
April 25, 2023/Cancer

Management of Lung Cancer Brain Metastases: An Update

We now have an expanded toolbox to extend survival and lessen treatment toxicity

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Grabowski, MD
January 24, 2023/Cancer

Study Explores Optimal Dosage of Novel Combination Therapy for Recurrent Glioblastoma

Focused ultrasound is paired with ALA to utilize sonodynamic therapy to target cancer cells

22-NEU-3409069-CQD-Hero-650×450
December 20, 2022/Cancer

Survival Is Associated With Subsets of T Cells in Recurrent Glioblastoma Treated With SL-701

Can T-cell immunophenotyping help inform treatment decisions?

22-NEU-3367462-T-cells-650×450
December 6, 2022/Cancer

Phase 1 Trial Shows Drug-Resistant Immunotherapy for Glioblastoma Is Safe and Feasible

Intracranial injection of supercharged immune cells proceeds to phase 2 testing

22-NEU-2826664-CQD-Hero-650×450 (1)
October 12, 2022/Neurosciences/Brain Tumor

Trigeminal Schwannoma: Two Surgical Options for Two Distinct Cases

Insights into the choice between craniotomy and endoscopic endonasal approaches

Pituitary gland
October 11, 2022/Neurosciences/Brain Tumor

Does Extended Use of Prophylactic Antibiotics Improve Nasal Healing After Endoscopic Transsphenoidal Surgery?

Randomized controlled trial finds no quality-of-life benefit after standard pituitary tumor surgery

22-NEU-3216908-CQD-Hero2-650×450
October 6, 2022/Cancer

Belzutifan for VHL-Associated CNS Hemangioblastoma: Here’s What Early Radiologic Response Looks Like

First reported imaging findings show swift reductions in perilesional edema, tumor size

BackPage 2 of 3Next

Advertisement

Ad